Mariner, LLC Takeda Pharmaceutical CO LTD Transaction History

Mariner, LLC

$55.8 Billion
Q3 2024

A detailed history of Mariner, LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Mariner, LLC holds 124,979 shares of TAK stock, worth $1.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

124,979

Previous 110,398 13.21%

Holding current value

$1.7 Million

Previous $1.43 Million 24.3%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$13.0 - $15.08 $189,553 - $219,881	14,581 Added 13.21%	124,979 $1.78 Million
Q2 2024 Aug 13, 2024	BUY	$12.6 - $13.67 $158,558 - $172,023	12,584 Added 12.87%	110,398 $1.43 Million
Q1 2024 May 15, 2024	BUY	$13.89 - $15.04 $326,026 - $353,018	23,472 Added 31.57%	97,814 $1.36 Million
Q4 2023 Feb 14, 2024	SELL	$13.36 - $15.43 $256,178 - $295,870	-19,175 Reduced 20.5%	74,342 $1.06 Million
Q3 2023 Nov 13, 2023	SELL	$15.03 - $16.32 $29,233 - $31,742	-1,945 Reduced 2.04%	93,517 $1.45 Million
Q2 2023 Aug 11, 2023	BUY	$15.57 - $17.11 $62,965 - $69,192	4,044 Added 4.42%	95,462 $1.5 Million
Q1 2023 May 12, 2023	BUY	$15.28 - $16.48 $257,666 - $277,902	16,863 Added 22.62%	91,418 $1.51 Million
Q4 2022 Feb 14, 2023	SELL	$12.42 - $15.62 $125,851 - $158,277	-10,133 Reduced 11.97%	74,555 $1.16 Million
Q3 2022 Nov 10, 2022	BUY	$12.8 - $28.65 $797,158 - $1.78 Million	62,278 Added 277.9%	84,688 $1.1 Million
Q2 2022 Aug 15, 2022	SELL	$13.12 - $15.03 $2,400 - $2,750	-183 Reduced 0.81%	22,410 $315,000
Q1 2022 May 13, 2022	BUY	$13.54 - $15.35 $305,909 - $346,802	22,593 New	22,593 $324,000

Others Institutions Holding TAK

# of Institutions

337

Shares Held

73.8M

Call Options Held

1.96M

Put Options Held

165K

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.

Account